Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients

The variation in response to ASA may be related with an increased expression of IGF1 and IGF1R, as well as a response to clopidogrel can be affected by pharmacokinetic change related to the reverse transport pathway by increased expression of ABCC3.